Revance Therapeutics Inc (RVNC)

[DewDiligence]

On today’s Wells Fargo webcast, Foley said the FDA site inspection in late June/early July was “routine.”

“Routine” sounds bullish. Bearish would’ve been “thorough,” “painstaking,” or (worst case) “interesting.”